We are live on ! Find out more
GC

Globeflex Capital Portfolio holdings

AUM $783M
1-Year Est. Return 81.58%
This Fund
S&P 500
This Quarter Est. Return
+34.81%
1 Year Est. Return
+81.58%
3 Year Est. Return
+185.88%
5 Year Est. Return
+280.02%
10 Year Est. Return
+1,365.88%
AUM
$783M
AUM Growth
+$122M
Cap. Flow
-$22.1M
Cap. Flow %
-2.82%
Top 10 Hldgs %
18.08%
Holding
456
New
69
Increased
67
Reduced
73
Closed
62

Top Buys

Rank Stock Value
1
CIEN icon
Ciena
CIEN
+$6.96M
2
MYRG icon
MYR Group
MYRG
+$4.57M
3
DRS icon
Leonardo DRS
DRS
+$4.16M
4
SMTC icon
Semtech
SMTC
+$3.99M
5
P
Everpure Inc
P
+$3.43M

Sector Composition

Rank Sector Weight
1 Technology 27.29%
2 Industrials 19.78%
3 Financials 17.73%
4 Healthcare 17.14%
5 Consumer Discretionary 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRS icon
51
Carpenter Technology
CRS
$19.9B
$4.9M 0.63%
7,937
+708
+10% +$333K
NBIX icon
52
Neurocrine Biosciences
NBIX
$15.3B
$4.78M 0.61%
28,363
+190
+0.7% +$28.2K
AMAL icon
53
Amalgamated Financial
AMAL
$1.41B
$4.75M 0.61%
103,401
-3,546
-3% -$150K
APPS icon
54
Digital Turbine
APPS
$1.34B
$4.75M 0.61%
367,860
-58,046
-14% -$347K
NBN icon
55
Northeast Bank
NBN
$1.14B
$4.68M 0.6%
35,339
PLOW icon
56
Douglas Dynamics
PLOW
$923M
$4.67M 0.6%
86,594
TOST icon
57
Toast
TOST
$17.8B
$4.53M 0.58%
162,676
+425
+0.3% +$11.1K
RNG icon
58
RingCentral
RNG
$6.19B
$4.47M 0.57%
114,766
+327
+0.3% +$13.2K
RIGL icon
59
Rigel Pharmaceuticals
RIGL
$859M
$4.41M 0.56%
112,672
-105,167
-48% -$3.24M
VCYT icon
60
Veracyte
VCYT
$3.25B
$4.38M 0.56%
74,576
+68,812
+1,194% +$2.89M
HSHP
61
Himalaya Shipping
HSHP
$907M
$4.26M 0.54%
318,651
OOMA icon
62
Ooma
OOMA
$615M
$4.24M 0.54%
220,363
RUSHB icon
63
Rush Enterprises Class B
RUSHB
$6.62B
$4.16M 0.53%
81,631
-7,382
-8% -$343K
PNTG icon
64
Pennant Group
PNTG
$1.42B
$4.13M 0.53%
111,813
DRS icon
65
Leonardo DRS
DRS
$9.9B
$3.99M 0.51%
+93,547
New +$4.16M
ACEL icon
66
Accel Entertainment
ACEL
$934M
$3.89M 0.5%
308,784
-54,208
-15% -$657K
LEVI icon
67
Levi Strauss
LEVI
$7.68B
$3.83M 0.49%
154,443
P
68
Everpure Inc
P
$34.4B
$3.69M 0.47%
+46,820
New +$3.43M
G icon
69
Genpact
G
$5.89B
$3.63M 0.46%
131,887
+427
+0.3% +$14K
CRNC icon
70
Cerence
CRNC
$368M
$3.5M 0.45%
+308,748
New +$3.02M
DVA icon
71
DaVita
DVA
$11.7B
$3.44M 0.44%
15,451
+2,391
+18% +$434K
INN
72
Summit Hotel Properties
INN
$620M
$3.42M 0.44%
487,570
CDNA icon
73
CareDx
CDNA
$2.81B
$3.4M 0.43%
119,252
AMAT icon
74
Applied Materials
AMAT
$330B
$3.25M 0.42%
4,496
DGII icon
75
Digi International
DGII
$2.75B
$3.25M 0.42%
43,366
+7,365
+20% +$457K

Similar funds

Globeflex Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Globeflex Capital held 456 positions worth $783M, up 18% from $661M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Globeflex Capital's Q2 2026 filing shows 69 new, 67 increased, 73 reduced and 62 closed positions. Its largest new stake was Ciena: 13,648 shares worth $6.7M. The largest sale was Catalyst Pharmaceutical, an estimated $11.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Industrials and Financials.

  • Globeflex Capital's largest Q2 2026 buy was Ciena: 13,648 shares worth $6.7M.
  • Globeflex Capital added most to MYR Group in Q2 2026, an estimated $4.57M increase.
  • Globeflex Capital's biggest Q2 2026 reduction was Rigel Pharmaceuticals, cutting an estimated $3.24M.
  • Globeflex Capital fully exited Catalyst Pharmaceutical in Q2 2026, selling an estimated $11.2M.
  • Globeflex Capital's ten largest holdings make up 18% of its $783M portfolio in Q2 2026.
  • Globeflex Capital opened 69 new positions and closed 62 in Q2 2026.
  • Globeflex Capital's portfolio value rose 18% quarter-over-quarter to $783M.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.